Peritoneal abnormalities during infectious episodes of continuous ambulatory peritoneal dialysis. 1981

J Rubin, and R Ray, and T Barnes, and J Bower

Exchanges were performed in 1-hour and 3- to 5-hour cycles when patients were noninfected and during episodes of peritonitis. The hourly exchange dialysate effluent volume decreased with the occurrence of peritonitis. These exchanges were associated with increased glucose absorption from dialysate, diminished sodium removal and augmented clearances of urea and creatinine. Protein losses were increased in the dialysate effluent of patients during an episode of peritonitis during the hourly exchanges. In the long-dwell exchanges obtained after clinical improvements of peritonitis, only protein losses were increased over control. Clearances, sodium loss in dialysate and glucose absorption were not altered from control.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D010538 Peritonitis INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. Primary Peritonitis,Secondary Peritonitis,Peritonitis, Primary,Peritonitis, Secondary
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose

Related Publications

J Rubin, and R Ray, and T Barnes, and J Bower
January 1986, Giornale di batteriologia, virologia ed immunologia,
J Rubin, and R Ray, and T Barnes, and J Bower
June 1991, The Journal of hospital infection,
J Rubin, and R Ray, and T Barnes, and J Bower
January 1980, Annals of internal medicine,
J Rubin, and R Ray, and T Barnes, and J Bower
November 1982, The International journal of artificial organs,
J Rubin, and R Ray, and T Barnes, and J Bower
December 1985, American heart journal,
J Rubin, and R Ray, and T Barnes, and J Bower
January 1986, European journal of clinical pharmacology,
J Rubin, and R Ray, and T Barnes, and J Bower
April 1981, Kidney international,
J Rubin, and R Ray, and T Barnes, and J Bower
January 1997, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis,
J Rubin, and R Ray, and T Barnes, and J Bower
October 1996, Clinical pharmacokinetics,
J Rubin, and R Ray, and T Barnes, and J Bower
July 1983, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!